Garrett Richard Rettig is a prominent inventor based in Coralville, IA (US). He has made significant contributions to the field of genetic engineering, particularly in the development of CRISPR technology. With a total of 12 patents to his name, Rettig's work has the potential to revolutionize gene editing.

Latest Patents

One of his latest patents focuses on S. pyogenes CAS9 mutant genes and polypeptides encoded by the same. This invention pertains to mutant Cas9 nucleic acids and proteins for use in CRISPR/Cas endonuclease systems, along with their methods of use. Specifically, the invention includes an isolated mutant Cas9 protein that is active in a CRISPR/Cas endonuclease system. This system displays reduced off-target editing activity while maintaining on-target editing activity compared to a wild-type CRISPR/Cas endonuclease system. Additionally, the invention encompasses isolated nucleic acids encoding mutant Cas9 proteins, ribonucleoprotein complexes, and CRISPR/Cas endonuclease systems featuring mutant Cas9 proteins that exhibit reduced off-target editing activity.

Career Highlights

Rettig is currently employed at Integrated DNA Technologies, Inc., where he continues to innovate in the field of genetic research. His work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

Some of his notable coworkers include Mark Aaron Behlke and Michael Allen Collingwood, who have also contributed to advancements in genetic engineering.

Conclusion

Garrett Richard Rettig's contributions to the field of CRISPR technology and genetic engineering are noteworthy. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and applications in this critical area.

This text is generated by artificial intelligence and may not be accurate.